Stryker Howmedica Osteonics Corp. Stryker T2 Ankle Arthrodesis Nail, left; 011 x 300 mm; Catalog Number: 18181130S; Sterile, TI Alloy; Stryker Trauma GmbH, Germany; Distributed in the US by Howmedica Osteonics Corp, Mahwah, NJ. Intended for tibiotalocalcaneal arthrodesis (fusion) and to provide stabilization of the hindfoot and ankle including the transverse tarsal joints coupling the mid-foot to the hindfoot. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Stryker T2 Ankle Arthrodesis Nail, left; 011 x 300 mm; Catalog Number: 18181130S; Sterile, TI Alloy; Stryker Trauma GmbH, Germany; Distributed in the US by Howmedica Osteonics Corp, Mahwah, NJ. Intended for tibiotalocalcaneal arthrodesis (fusion) and to provide stabilization of the hindfoot and ankle including the transverse tarsal joints coupling the mid-foot to the hindfoot.
Brand
Stryker Howmedica Osteonics Corp.
Lot Codes / Batch Numbers
lot codes: K152966, K177319, K208221, K230272, K254574, K735537, K779942, K841062, K842726, K868798, K868816, K883947, and K892961.
Products Sold
lot codes: K152966, K177319, K208221, K230272, K254574, K735537, K779942, K841062, K842726, K868798, K868816, K883947, and K892961.
Stryker Howmedica Osteonics Corp. is recalling Stryker T2 Ankle Arthrodesis Nail, left; 011 x 300 mm; Catalog Number: 18181130S; Sterile, TI Alloy; due to Stryker Orthopaedics became aware that there is the potential for damage to the sterile packaging of the product during transport.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Stryker Orthopaedics became aware that there is the potential for damage to the sterile packaging of the product during transport.
Recommended Action
Per FDA guidance
Urgent Product Recall notification letters were sent to branches on 12/29, 2009, with a corrected version that included a list of catalog numbers and code numbers on January 11, 2009. Letters were also sent by Fed Ex on January 11, 2009 to Hospital Risk Management, Chief of Orthopaedics and surgeons who may have used the device. The letters identified the affected product, described the issue, and the hazards involved. The letter also asked customers to examine their inventory and hospital locations to identify the affected product. They are to retrieve all affected product and return it to their branch or agency warehouse for reconciliation. Customers are to reconcile all products utilizing the Product Recall Accountability Form. Questions should be directed to 201-972-2100.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026